The Russian vaccine against SARS-CoV-2 was developed by the Gamaleya Research Institute in cooperation with the Russian Ministry of Defense. After completing the two stages of the Russian vaccine, the project manager said he had already injected himself with the vaccine.
Cite this article:
Ali A. Dawood. The Russian Vaccine of COVID-19 (Sputnik V) has shown side effects on the Volunteers. Asian Journal of Research in Pharmaceutical Sciences. 2021; 11(3):193-4. doi: 10.52711/2231-5659.2021.00030
Ali A. Dawood. The Russian Vaccine of COVID-19 (Sputnik V) has shown side effects on the Volunteers. Asian Journal of Research in Pharmaceutical Sciences. 2021; 11(3):193-4. doi: 10.52711/2231-5659.2021.00030 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2021-11-3-2
1. Logunov D, Dolzhikova I, and Zubkova O. et al. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia. The Lancet. 2020; Sep.:1-11. https://doi.org/10.1016/S0140-6736(20)31866-3.
2. Turak N. Russia’s potential coronavirus vaccine shows ‘no serious adverse’ effects and creates antibody response: The Lancet study. CNBC. 2020; Sep.: 4. https://www.cnbc.com/2020/09/04/russian-coronavirus-vaccine-shows-no-serious-side-effects-lancet-says.html.
3. Times of India. Controversial Russian coronavirus vaccine shows immune response; no major side-effects reported, shares Lancet study. Etimes. 2020; Sep.:8. https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/controversial-russian-coronavirus-vaccine-shows-immune-response-no-major-side-effects-reported-shares-lancet-study/photostory/77997057.cms.
4. Rokade M, and Khandagate P. Coronavirus disease: A review of a New Threat to Public Health. Asi J Pharm Res. 2020;10(3):241-244. https://doi:10.5958/2231-5691.2020.00042.8.
5. Prathmesh J, Manohar K, Ravina J, Aishwarya S, Shweta. K, and Honmane P. On overview- Corona virus and Hanta virus Disease. 2020;10(3):178-182. https://doi:10.5958/2231-5659.2020.00034.X.
6. Dawood A, Alnori H. Tunicamycin Anticancer Drug May Reliable to Treat Coronavirus Disease-19. OAMJMS. 2020; 8(T1):129-133. https://doi.org/10.3889/oamjms.2020.4954.
7. Naresh B. A Review of the 2019 Novel Coronavirus (COVID-19) Pandemic. Asian J. Pharm. Res. 2020; 10(3):233-238.
8. Nikhat F, Thouheed A, and Moid A. Sars-CoV-2leader-RNA-primed Transcription and RNA-Splicing prevention, control and Treatment. Asian J. Research Chem. 2020; 13(4):291-298.
9. Abdul Kader M. An Extensive Review of Health and Economy of Bangladesh amid Covid-19 Pandemic. Int. J. Rev. and Res. Social Sci. 2020; 8(2): 108-117.
10. Akshay Y, and Shrinivas M. A Novel Approach for Treatment of COVID-19 with Convalescent Plasma. Res. J. Pharma. Dosage Forms and Tech. 2020; 12(3): 227-230.
11. Pankaj S, Pankaj M, Pushpendra K, and Himanshu J. Turmeric: Plant Immunobooster against COVID-19. Res. J. Pharmacognosy and Phytochem. 2020; 12(3): 174-177.
12. Paresh A, Patil, and Ritik. J. Theoretical Study and treatment of Novel COVID-19. Res. J. Pharmacology and Pharmacodynamics. 2020; 12(2): 71-72.
13. Sarfaraz A, Ambreen S, Sajid A, Sarfaraz A, Nawazish A, Maksood A, Ali M, Ayaz A, Salahuddin A, and Mohammad A. Epidemiology, risk, myths, pharmacotherapeutic management and socioeconomic burden due to novel COVID-19: A recent update. Research J. Pharm. and Tech. 2020; 13(9):4435-4442.